This HTML5 document contains 205 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1038/
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q48261561
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ artigo científico 2017年学术文章 videnskabelig artikel (udgivet 2017) artículo científico publicado en 2017 научная статья vetenskaplig artikel 2017年学术文章 mokslinis straipsnis 2017年の論文 2017年學術文章 artikull shkencor artigo científico (publicado na 2017) wetenschappelijk artikel article scientific tudományos cikk مقالة علمية наукова стаття, опублікована в червні 2017 ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article scientifique (publié 2017) artigo científico (publicado na 2017) գիտական հոդված naučni članak vědecký článek 2017년 논문 2017年學術文章 bilimsel makale научни чланак научна статия tieteellinen artikkeli scientific article מאמר מדעי 2017 nî lūn-bûn teaduslik artikkel 2017年學術文章 wissenschaftlicher Artikel 2017年学术文章 мақолаи илмӣ مقالهٔ علمی bài báo khoa học سائنسی مضمون επιστημονικό άρθρο vedecký článok articolo scientifico სამეცნიერო სტატია artykuł naukowy artikulong pang-agham 2017年学术文章 2017年學術文章 artículu científicu 2017年学术文章 articol științific vitskapeleg artikkel article científic scienca artikolo 2017年學術文章 2017年學術文章 научни чланак บทความทางวิทยาศาสตร์ vitenskapelig artikkel
p:P577
wds:Q48261561-FF7A7D7B-865B-47ED-9077-A88DC42B2C75
wdt:P577
2017-06-19T00:00:00Z
p:P2888
wds:Q48261561-CC20F847-4F78-437E-869A-0B89D3C590F7
wdt:P2888
n10:leu.2017.193
p:P2860
wds:Q48261561-FFD6C679-E0C6-4870-BC8D-817F9DE0B4EA wds:Q48261561-C7C9F66F-E4B1-46CA-A295-9DC150117829 wds:Q48261561-CA8EE739-073C-450F-A768-E7D89C235F99 wds:Q48261561-B89553AF-A8EA-453D-A0FD-7D5CBD8978EA wds:Q48261561-BC1FD2ED-BB2D-44D9-88D0-0D04DCDBC83F wds:Q48261561-BFC4D376-35B4-468D-ACFC-8AEABF4A2139 wds:Q48261561-C21A120A-76A0-4DCE-83A6-34E33BACA61F wds:Q48261561-E5AA461C-8A39-43EA-92C0-BBF283060CD6 wds:Q48261561-F036D108-05B0-444B-ADFB-4E583733FAEF wds:Q48261561-DA112C69-1C7D-479F-9513-CFC80037676F wds:Q48261561-893472E9-65C1-4C42-AC4C-B997B6B095D8 wds:Q48261561-94287A21-5E39-49B1-93F5-7E7A94BFFE61 wds:Q48261561-9678EF9C-5A3C-405F-84FB-5A9B8E29DD00 wds:Q48261561-7D8E0702-308C-4F5D-8FBD-E0EEAB0892BD wds:Q48261561-827DF512-4B2C-4292-BCA9-69C32D5A97C3 wds:Q48261561-83C191B2-6740-427D-893C-515BBF216034 wds:Q48261561-83DDADB7-87B4-4417-AF0A-08BDD3D72BEA wds:Q48261561-A970669E-8E69-45A0-B385-48404C947109 wds:Q48261561-B1D9C00B-1D6F-43E8-992B-6BA3CD49E482 wds:Q48261561-B29A6D18-AAB5-4263-B731-C85D38062C9D wds:Q48261561-B60A90AC-96CD-469F-85E1-4B32CF3ECEA2 wds:Q48261561-9E9A7CA8-6018-4FF8-9198-10D8E1C934A1 wds:Q48261561-A06C2A89-14CB-4E30-93E9-F5E449A7DDAC wds:Q48261561-5B7C09E0-A91F-4020-BB84-3FDADCE54B4D wds:Q48261561-5D376E18-8B6F-4543-9D13-7D7FAE64FE28 wds:Q48261561-4E1CC4AF-5370-417C-88F2-8263082AED54 wds:Q48261561-7118C921-1936-45E6-B4E7-A1AD4001E368 wds:Q48261561-2485A71B-9FA8-4A05-B49B-E2ABA5481A2A wds:Q48261561-73567862-9B7E-4AA3-AF5C-1455AED18FCC wds:Q48261561-2741F845-ADB3-4C59-9E20-494D6E82D660 wds:Q48261561-781F05B6-0069-498B-989D-D001714C24F8 wds:Q48261561-2B555153-6240-4187-BE4B-439ECA2494F4 wds:Q48261561-7B1881BF-8692-4675-A1C8-8370C2DF0D03 wds:Q48261561-60D6655F-3086-4DB2-9820-520F3C55A11A wds:Q48261561-11481E11-2E27-4357-996F-6634919815FE wds:Q48261561-1BEF743A-2B4E-4507-967C-6933C0532878 wds:Q48261561-645B4155-FC2B-4CCB-B50C-D1B7DB3933FD wds:Q48261561-1D086B26-39CE-4949-9A5A-F4B49505FE88 wds:Q48261561-20081AB4-D605-4598-A9EA-4339E27BE3DE wds:Q48261561-3B3CCC23-3EE1-44E6-A30E-03F0ED6DF261 wds:Q48261561-43FC986F-9787-40EB-9F1D-87F0875AF0E8 wds:Q48261561-3486A695-085A-4BF4-B38B-597AEB981298 wds:Q48261561-377054A5-2FE2-4135-AA15-9D2E6A085843 wds:Q48261561-38566250-B609-4DAD-96B2-CBDEDC90BFE5 wds:Q48261561-03B6286D-38A9-4121-A6D8-F04A6291264A
wdt:P2860
wd:Q36065902 wd:Q28145893 wd:Q54707687 wd:Q36441894 wd:Q35961926 wd:Q35849746 wd:Q84573386 wd:Q34556828 wd:Q36806793 wd:Q37398320 wd:Q29614350 wd:Q28577206 wd:Q27690653 wd:Q33680309 wd:Q36162703 wd:Q29614349 wd:Q40316330 wd:Q36829147 wd:Q47884316 wd:Q34993852 wd:Q37097929 wd:Q28646286 wd:Q34029353 wd:Q36935291 wd:Q36889961 wd:Q29620350 wd:Q29620642 wd:Q41910513 wd:Q29547438 wd:Q35877268 wd:Q36839558 wd:Q74129138 wd:Q46516651 wd:Q34429912 wd:Q29615845 wd:Q48276186 wd:Q34579769 wd:Q68118175 wd:Q41927849 wd:Q74643145 wd:Q36692838 wd:Q37194943 wd:Q27016634 wd:Q34279134 wd:Q38167996
p:P2093
wds:Q48261561-4DDCE86B-9E6A-4375-AA47-2A837D147D65 wds:Q48261561-512ECD9E-E28B-4CF1-AD6F-AB9D10257656 wds:Q48261561-6797E6A3-A984-480C-A95C-B1D1B347EB28 wds:Q48261561-856AD72D-B795-4BEF-A220-E53F63660765 wds:Q48261561-C5B356CA-9CDF-49A3-91FA-BAB24A03AFCC wds:Q48261561-E4AC0C4A-494F-4324-9D88-6D766244E084 wds:Q48261561-0D4C939D-C0E1-4995-8B91-D107726C0329 wds:Q48261561-0010593C-443F-45E6-B244-CB78EBFFACD2 wds:Q48261561-461C48F4-5854-4C47-B7BD-0849ADD2780F wds:Q48261561-3E27CC4E-BAE8-4F78-9B97-CA82D6B904BA
wdt:P2093
Y Jiang R Li Y Lu Y Zheng C Zheng J Hou Q Yi E Bi S Wang J Qian
rdfs:label
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma. Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma.
skos:prefLabel
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma. Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma.
schema:name
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma. Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma.
p:P50
wds:Q48261561-EDF68DA4-3E51-4263-ACB3-F1DD1AC68723
wdt:P50
wd:Q57020222
p:P1476
wds:Q48261561-46F56942-0EEF-4E02-82BD-881CD879527D
wdt:P1476
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma.
p:P304
wds:Q48261561-9A5882E9-7AE3-4825-9C27-668ACB82237C
wdt:P304
176-183
p:P31
wds:Q48261561-392C829A-10BF-4EAC-9011-6FB199B6F7ED
wdt:P31
wd:Q13442814
p:P698
wds:Q48261561-A104B6B2-3305-4494-97B1-252A1FE393AE
wdtn:P698
n13:28626216
wdt:P698
28626216
p:P1433
wds:Q48261561-2DFB10D9-A6CE-4288-9608-F7BAF07D5598
wdt:P1433
wd:Q6534498
p:P433
wds:Q48261561-E187B541-0B60-44E9-8382-C5546E499763
p:P478
wds:Q48261561-CE87CC97-4A68-412C-957D-DE31541E9A71
wdt:P433
1
wdt:P478
32
p:P356
wds:Q48261561-5AF23797-7B1B-4585-B269-F8F32F285663
wdtn:P356
n12:LEU.2017.193
wdt:P356
10.1038/LEU.2017.193
p:P6179
wds:Q48261561-4A57088B-21A7-4540-97A3-7938637D628E
wdt:P6179
1086091281
p:P932
wds:Q48261561-613D037E-9F22-4B28-A006-9C482899D6F6
wdt:P932
5927777